← All stocks

Aldeyra Therapeutics, Inc.

ALDX Net buying

CIK 0001341235 #4374 in the set updated 18 Sep 2026

Bought (12 mo)

$523.55K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$523.55K

+$523.55K against sales at will

By person

5 insiders · 3 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Brady Todd C

President and CEO

$418.45K (1)

—

+$418.45K

1,721,298

2.85%

$2.88M

+17.0%

DOUGLAS RICHARD

Director

$98.00K (1)

—

+$98.00K

195,000

0.3232%

$326.39K

+56.0%

Alfieri Michael

Principal Financial Officer

$7.10K (1)

—

+$7.10K

7,500

0.0124%

$12.55K

—

PERCEPTIVE ADVISORS LLC entity

10% owner

—

5,875,851

9.74%

$9.83M

−36.7%

Machatha Stephen

Chief Development Officer

—

221,799

0.3677%

$371.25K

−9.1%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 11

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 14 Sep 2016